Piritramid (analgetic) — Competitive Intelligence Brief

Piritramid (analgetic) (Piritramid (analgetic)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid analgesic. Area: Pain Management.

marketed Opioid analgesic Mu opioid receptor Pain Management Small molecule

Target snapshot

Piritramid (analgetic) (Piritramid (analgetic)) — Technische Universität Dresden. Piritramid is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system to produce analgesia.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Piritramid (analgetic) TARGET	Piritramid (analgetic)	Technische Universität Dresden	marketed	Opioid analgesic	Mu opioid receptor
NALBUPHINE HYDROCHLORIDE	NALBUPHINE HYDROCHLORIDE		marketed		kappa opioid receptors, mu opioid receptors	1979-01-01
PCM/Oxy1	PCM/Oxy1	Maastricht University Medical Center	marketed	Opioid analgesic combination	Mu opioid receptor (oxycodone); COX enzymes (paracetamol)
lidocaine and sufentanil	lidocaine and sufentanil	RenJi Hospital	marketed	Local anesthetic and opioid analgesic combination	Voltage-gated sodium channels (lidocaine); mu opioid receptor (sufentanil)
Ibuprofen + Paracetamol + Codeine	Ibuprofen + Paracetamol + Codeine	Ullevaal University Hospital	marketed	Combination analgesic (NSAID + acetaminophen + opioid)	COX-1/COX-2 (ibuprofen, paracetamol); mu opioid receptor (codeine)
Acetaminophen-Hydrocodone	Acetaminophen-Hydrocodone	Le Bonheur Children's Hospital	marketed	Opioid analgesic combination	Mu opioid receptor (hydrocodone component); prostaglandin synthesis inhibition (acetaminophen component)
Bupivacaine-fentanyl elective group	Bupivacaine-fentanyl elective group	Conrad Arnfinn Bjørshol	marketed	Local anesthetic with opioid analgesic combination	Voltage-gated sodium channels (bupivacaine); mu opioid receptor (fentanyl)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid analgesic class)

1. Alza Corporation, DE, USA · 3 drugs in this class
2. Labopharm Inc. · 3 drugs in this class
3. University of Rochester · 3 drugs in this class
4. Purdue Pharma LP · 3 drugs in this class
5. Institute of Child Health · 2 drugs in this class
6. London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 2 drugs in this class
7. Fujian Cancer Hospital · 2 drugs in this class
8. Children's Hospital of Fudan University · 2 drugs in this class
9. AdventHealth · 2 drugs in this class
10. Danish University of Pharmaceutical Sciences · 2 drugs in this class